Company
Introduction CEO Greeting Leadership R&D Experience History Partner
New Drug R&D Repositioning Clinical Translational
Research
PRIINT Orthotopic Animal Model Novel Drug Development
Pileline Stautus PBS203 PBL201 PBL211
Non clinical trials efficacy evaluation services Tissue Pathology Analysis
News Contribution
Notice Financial Information IR Contact
Location Study Request What We Value Corporate Culture
연구의뢰 연구의뢰

PLATFORM

PRIINT

Accurate and accelerated tumor target discovery platform PRIINT Discovered 50 novel targets from just two indications of pancreatic cancer and ovarian cancer

PRIINT Characteristics

  1. 01 Establish orthotopic model for specific tumors
  2. 02 Tumor target discovery and verification
  3. 03 Cross-checking of tumor targets using tumor tissues and blood

PRIINT Advantages

  1. 01 Reduce the gap between
    preclinical stages and clinical stages
  2. 02 Reduce the cost and time for
    novel drug development
  3. 03 Cost-effective development with
    re-utilization of existing clinical products subs